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In vivo replication of rotaviruses is generally limited to enterocytes. Because of this restriction, most blood circulating
rotavirus-specific B cells are hypothesized to originate in Peyer’s patches and should express the intestinal homing receptor
47. To test this hypothesis in humans, we used a flow cytometry assay that identifies antigen-activated (IgD) B cells
(CD19) that express surface rotavirus-specific immunoglobulin. With this assay we could detect rotavirus-specific B cells in
both children and adults with an acute rotavirus (RV) infection. Staining with an anti-47 monoclonal antibody, we could
determine that B cells that express rotavirus-specific surface immunoglobulin predominantly express 47. The response of
rotavirus-specific antibody-secreting cells in the peripheral blood of children and adults with acute rotavirus infection was
also studied by ELISPOT. The antibody-secreting cells of children were mainly of the IgM isotype, while the antibody-
secreting cells of adults were predominantly of the IgA and IgG isotype. 47 and 47 subsets of peripheral blood
mononuclear cells were purified using paramagnetic beads and then tested in the ELISPOT assay. Rotavirus-specific
antibody-secreting cells were predominantly present in the 47 subpopulation. The flow cytometry assay we have
described will permit future studies to characterize the phenotype of virus-specific B cells and could be useful in the study
of the immunogenicity and protective efficacy of RV vaccines and the identification of markers of protective immunity. © 2002Key Words: rotavirus; mucosal immunology; B cells; hom
INTRODUCTION
Rotavirus (RV) is the most important cause of severe
dehydrating diarrhea in children in both developed and
less developed countries. It is estimated that RVs are
responsible for the death of approximately 1600 children
daily worldwide (Bresee et al., 1999). Studies of RV in-
fection in animal models have highlighted the impor-
tance of the intestinal mucosal immune response in
immunity to this pathogen (Franco and Greenberg, 1999).
Protection from reinfection is principally mediated by
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antibody, most probably intestinal IgA (Franco and
Greenberg, 1999). In addition to RV-specific intestinal
IgA, circulating RV-specific antibody-secreting cells (RV-
ASC) (Yuan et al., 1996) have also been shown to corre-
late with protection against viral reinfection in the pig
model. Moreover, the RV-ASC detected in the blood of
pigs infected with RV very closely reflected the number of
intestinal lamina propria RV-ASC of the same pigs (Yuan
et al., 1996). In humans, intestinal IgA has also been
correlated with protection from reinfection (Coulson et
al., 1992), and the measurement of circulating RV-ASC
has been useful in the study of the immunogenicity of RV
vaccines (Isolauri et al., 1995). Recently a correlation was
shown between the presence of circulating and small
intestinal RV-ASC in older children (Brown et al., 2000). In
this study blood and intestinal RV-ASC were identified
after enrichment for cells that express the CD38 marker,
a process that increases the likelihood of detecting an-
tigen-specific ASC (Brown et al., 2000; Lakew et al.,
1997).
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secondary lymphoid organs until they encounter antigen.
After antigen-specific activation, the B cell migration pat-
tern changes, redirecting them preferentially to the tis-
sue where the activating antigen was originally encoun-
tered (Butcher et al., 1999). This tissue-specific migration
provides the B lymphocyte with the best chance of reen-
countering the antigen that originally stimulated it. The
homing of lymphocytes stimulated by antigens first en-
countered in intestinal Peyer’s patches (PP) back to other
PP or the intestinal lamina propria is mediated, in part, by
interactions between the integrin 47, expressed on B
lymphocytes, and the cell adhesion molecule MadCAM
1, expressed on the vascular endothelium of the post-
capillary venules in intestine (Butcher et al., 1999). Re-
cent studies of the expression and function of 47 on B
cells have provided evidence that supports this model in
humans (Rott et al., 2000). According to this model, the
close correlation in both pigs and humans of intestinal
lamina propria RV-ASC with blood RV-ASC, mentioned
above, is due to the fact that the latter are the precursors
of the former during their transit from PP to the lamina
propria.
Because RVs replicate almost exclusively in entero-
cytes, they are an excellent model for studying mucosal
immunization (Greenberg et al., 1994). Thus, the immune
response against RV originates in the intestine, and
effector functions are carried out directly in the intestinal
mucosa. Based on this fact and the intestinal lymphocyte
migration model described above, several studies have
addressed the presence of the intestinal homing recep-
tor 47 on RV-specific lymphocytes. Using FACS-puri-
fied 47 / subsets of peripheral blood T cells, we
demonstrated that human RV-specific CD4 T cells ex-
press the gut-homing marker 47 (Rott et al., 1997). In
the murine model, adoptive transfer experiments of
memory CD8 T cells revealed that cells capable of
mediating RV-clearance preferentially express 47
(Rose´ et al., 1998). However, recent experiments using
7 / mice show that expression of the intestinal
homing integrin 47 is not essential for CD8 T cells to
migrate to the intestine and provide immunity to RV
(Kuklin et al., 2000). Passive B cell transfer experiments
provided evidence that mice receiving 47 hi/memory
(IgD), but not those receiving 47/memory (IgD)
or naive (IgD) B cells, produced RV-specific IgA in the
stool, cleared the virus, and were immune to reinfection
(Williams et al., 1998). In contrast to the experiments with
CD8 T cells, using 7 / mice we showed that mu-
rine B cells do require 47 to migrate to the intestine
and mediate RV immunity (Kuklin et al., 2001).
In the present study we sought to determine if, as
predicted by the studies in the murine model, human
RV-specific B cells express the 47 integrin on their
surface. Using a novel flow cytometry assay that permits
the characterization of B cells that express RV-specific
surface (cell membrane bound) Ig (RV-SIg) (Kuklin et al.,
2001; Youngman et al., 2002) and B cell ELISPOTS, we
have determined that this is the case for the majority of
human B cells.
RESULTS
Quantification and phenotype of B cells that express
RV-SIg by flow cytometry
To characterize the phenotype of B cells that express
RV-SIg in recently RV-infected adults and children, we
used a flow cytometry based assay previously validated
in the mouse model (Kuklin et al., 2001; Youngman et al.,
2002). The principle of this assay consists of the specific
binding of a fluorescent RV antigen to a B cell that
expresses RV-SIg. As an antigen we chose recombinant
virus-like particles (VLP) made from RV VP6 protein and
a fusion protein consisting of GFP fused to the N termi-
nus of RV VP2 deleted of its first 92 amino acids (Charpili-
enne et al., 2001). We chose this antigen because an
important proportion of the RV-specific cross-reactive
antibody response in children is directed at VP2 and VP6
(Johansen et al., 1994). In addition to the GFP-VLPs, the
cells are also stained with fluorochrome-labeled Mabs
directed against a B cell marker (CD19), IgD (to distin-
guish antigen activated from naive B cells), a Mab
against 47, the intestinal homing receptor, and then
analyzed in a flow cytometer. For the analysis of these
experiments, cells are first gated on CD19 IgD cells.
Then, the cells are classified into subsets of large and
small cells based on their forward and side-scatter prop-
erties. Dot plots of GFP-VLPs vs 47 from each of these
cell subsets were created, and the results expressed as
the number of CD19, IgD, GFP-VLPs, 47, or
47 cells  100/CD19, IgD total cells. Figure 1
shows representative examples of these experiments
gated on the large cells from a child (Fig. 1a) and an adult
(Fig. 1b) infected with RV, and a child (Fig. 1c) and an
adult nonrecently infected with RV (Fig. 1d).
Tables 1 and 2 show the results of these experiments
for both large and small cells in individual adults and
children with RV-induced diarrhea and asymptomatic
adults recently infected with RV. The percentage of large
and small cells with RV-SIg from children in the acute
[between 1 to 7 days after onset of the diarrhea (DAOD)]
and the convalescent (between 7 to 30 DAOD) phases of
RV-induced diarrhea were similar (P  0.53 Mann–
Whitney test), so these results were pooled for analysis
and are shown in comparison with the results from
children with non-RV-induced diarrhea in Fig. 2. The
percentage of large and small cells with RV-SIg from
symptomatic or asymptomatic recently RV-infected
adults (Table 1) was not significantly different (P  0.48
Mann–Whitney test), so these results were also pooled
for analysis and are shown in Fig. 2 with the results from
healthy adults. The percentage of small cells with RV-SIg
(both 47 and 47 subsets) did not differ signifi-
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cantly (P  0.11 Kruskal–Wallis test) between the four
study groups; however, there was a trend for higher
levels in the symptomatically RV-infected 47 adult
group (Fig. 2a). Also, the percentage of large 47
cells with RV-SIg did not differ significantly (P  0.24
Kruskal–Wallis test) between the four study groups (Fig.
2b). In contrast, the percentage of large cells 47 with
RV-SIg did differ significantly (P  0.001 Kruskal–Wallis
test) between the four study groups. Both recently RV-
infected adults and RV-infected children had significantly
(P  0.01 Mann–Whitney test) greater percentages of
large 47, CD19, IgD, GFP-VLPs cells than non-
FIG. 1. Flow cytometry analysis of large cells from a child (a) and an adult (b) infected with RV, and a child (c) and an adult not recently infected
with RV (d). PBMC from each of the subjects were purified on a Ficoll gradient, then stained with Mabs against IgD, CD19, and 47 and with
GFP-VLPs, washed, and acquired in a flow cytometer. For analysis, cells were gated on the CD19 IgD subpopulation and with these events, a
forward scatter (FSC) vs side scatter (SSC) plot was made. Based on these plots, two populations of cells were defined: small cells and large cells.
Based on these subpopulations of events, dot plots were created separately on small and large cells showing expression of 47 and GFP-VLP
fluorescence. In this figure only graphs showing expression of 47 and GFP-VLP fluorescence gated on the large cells are shown. The % of
GFP-VLPs, 47, or  large IgD B cells are shown in each quadrant.
TABLE 1
B Cells That Express RV-SIg in Recently Infected Adults
Subjects
Age
(years) DAOD
% CD19, IgD, GPFVLP
Small cells Large cells
47 47 47 47
A 1 28 5 2.52 0.32 15.16 0.21
A 2 27 8 0.12 0.19 1.82 0.4
A 3 47 14 0.35 0.23 1.94 0.67
A 4 11 15 0.3 0.39 1.7 0.24
A 5 45 A 0.17 0.02 1.4 0.28
A 6 28 A 0.02 0.00 0.57 0.16
A 7 27 A 0.63 0.11 0.36 0.09
Note. Values above the mean  2 SD of the results from the corresponding small and large cells of non-RV-infected adults are shown in bold. A:
asymptomatic.
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RV-infected adults or children. This difference remained
statistically significant (P  0.01 Mann–Whitney test)
even when the comparisons between cells of infected
and noninfected adults omitted volunteer A1 (a volunteer
that could potentially represent an outlier, Table 1). In
RV-infected adults and children the percentages of large
CD19, IgD, GFP-VLPs, 47 was greater than the
47 cells (P  0.018 Wilcoxon test). Nonetheless,
the mean ratio of 47/47 cells was significantly
greater (P  0.037 Mann–Whitney test) in adults (21.67)
than children (3.07).
Correlation in children between circulating B cells
with RV-SIg and the presence of RV-specific fecal and
plasma antibodies
According to the intestinal lymphocyte migration
model, our capacity to detect RV-specific B cells among
the PBMC of children and adults infected with RV is due
to the fact that these cells have been recently primed in
PP and are on their way back to the intestine, where they
will produce intestinal antibodies (Butcher et al., 1999).
This model predicts that 47 RV-specific B cells
should correlate with the presence of RV-specific intes-
tinal antibodies. Although fecal antibodies may not be an
ideal surrogate for measuring intestinal antibodies
(Franco and Greenberg, 2001), we tested whether we
could find correlations between the presence of circulat-
ing RV-SIg B cells and the presence of fecal RV-specific
antibodies. We found a correlation between large 47
RV-SIg B cells (determined in experiments with PBMC
from children in both the acute and the convalescent
phase of the disease) and convalescent fecal IgM titers
(P  0.047; r  0.58 Spearman’s test, Fig. 3a). In
contrast, 47 RV-SIg large B cells did not show a
statistically significant correlation with convalescent fe-
cal IgM titers (P  0.5; r  0.21 Spearman’s test).
Neither 47 or 47 cells correlated with fecal IgA
convalescent titers (P  0.69; r  0.12 Spearman’s
test). The 47 (P  0.007; r  0.73 Spearman’s test,
Fig. 3b) but not the 47 (P  0.1; r  0.49 Spear-
man’s test) large cells correlated with convalescent
plasma IgM titers. Neither 47 or 47 cells cor-
FIG. 2. Mean and SEM of % CD19, IgD, RV-SIg, 47/ small
(a) and large (b) subsets of B cells in the different study groups:
children with RV-induced diarrhea (RV) (n  14 from Table 1),
children with non-RV-induced diarrhea (RV) (n  7), recently RV
infected (symptomatic and asymptomatic) (RV) adults (n  7, Table
2), and a group of healthy adults (RV) (n  12). * Significant differ-
ences (P  0.01 Mann–Whitney test) with the percentage of cells from
the non-RV-infected adults or children and with the corresponding
levels of 47 cells of the same study group (P  0.018 Wilcoxon
test).
TABLE 2
B Cells that Express RV-SIg in Children with RV Induced Diarrhea
Subjects
Age
(months) DAOD
% CD19, IgD, GPFVLP
Small cells Large cells
47 47 47 47
C 01 20 1.5 0.11 0.19 0.69 0.24
C 02 9 2 2.09 1.05 3.11 2.29
C 03 18 4 0.37 0.23 0.22 0.04
C 04 8 4 0.39 0.44 1.88 1.21
C 05 10 4.5 0.12 0.41 0.81 0.5
C 06 10 5 0.35 0.31 0.3 0.45
C 07 39 6 0.23 0.03 0.5 0.06
C 08 10 11 0.19 0.13 0.22 0.11
C 04 8 13 0.54 0.77 1.24 0.98
C 09 11 14 0.35 0.37 3.99 4.17
C 10 6 15 0.28 0.64 2.04 0.17
C 11 30 17 0.32 0.48 1.26 1.22
C 01 20 23 0.04 0.14 0.03 0.18
C 03 18 23 0.37 0.31 0.71 0.19
Note. Values above the mean  2 SD of the results from the
corresponding small and large cells of non-RV-infected children are
shown in bold.
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related with IgA convalescent plasma titers (P  0.26;
r  0.07 Spearman’s test).
Quantification of RV-ASC in children with RV-induced
and non-RV-induced diarrhea
Previous investigators have studied the RV-ASC
present in PBMCs of children with acute RV-induced
diarrhea (Kaila et al., 1992). To extend these studies to
more precisely identify the peak of the ASC in relation to
the DAOD, we performed ELISPOT assays in children
with different DAOD (Table 3). We found considerable
variability in the presence of ASC in relation to the time
after onset of diarrhea: between 1 and 2 DAOD, 5 of 10
children did not have detectable ASC; between 3 and 6
DAOD, 1 of 11 children did not have detectable ASC;
between 8 and 23 DAOD, 5 of 11 children did not have
RV-ASC. For seven of the children (children numbers C
10, C 01, C 14, C 18, C 02, C 09, C 03) we could perform
the assay twice (the blood samples used for these two
assays were taken with an interval of approximately 2
weeks, Table 3). For 1 child (C 10) the ASC increased
from the acute to the convalescent phase, while for the
remaining six children the ASC decreased (C 01, C 02, C
09, C 03) (Table 3) or were not detectable in either
sample (C 18 and C 14). These results, and the results of
previous studies (Kaila et al., 1992), suggest that the peak
TABLE 3
RV-ASC of IgM, IgG, and IgA Isotype in Children
with RV-Induced Diarrhea
Subjects
Age
(months) DAOD
Primary
infectiona
Number of ASC per
106 PBMC
IgM IgG IgA
C 12 17 1 Yes 15 0 0
C 10 6 1 Yes 0 0 0
C 01 20 1.5 Yes 17 0 2
C 13 15 1.5 Yes 0 10 0
C 14 8 1.5 Yes 0 0 0
C 15 6 1.5 Yes 3.5 0 2
C 16 24 2 Yes 0 0 0
C 17 14 2 Yes 0 0 0
C 18 10 2 No 0 0 0
C 02 9 2 Yes 757.5 0 225
C 19 4 3 Yes 2 0 0
C 09 11 3 Yes 52 0 2.5
C 20 7 3 Yes 0 4 0
C 21 5 3 Yes 6.75 0 2
C 22 24 3.5 Yes 0 0 2
C 03 18 4 No 5.5 0 8
C 04 8 4 Yes 48 0 0
C 23 30 4.5 Yes ND 0 15
C 05 10 4.5 No 0 15 9
C 24 18 6 Yes 0 0 0
C 25 3.5 6 No 18 ND ND
C 26 30 8 No 0 0 0
C 27 13 8 No 44 0 4
C 28 6 8 No 17 2 8
C 29 11 11 Yes 4.5 0 0
C 09 11 14 Yes 2 0 0
C 18 10 14 No 0 0 0
C 14 8 14 Yes 0 0 0
C 02 9 15 Yes 8 10 68
C 10 6 15 Yes 13 4 18
C 01 20 23 Yes 0 0 0
C 03 18 23 No 0 0 0
a Determined by the absence of RV-specific IgA in plasma or stool
samples from the acute phase samples of the child. ND, not done.
Values above the mean  2 SD of the results from ASC of the
corresponding isotype of non-RV-infected children are shown in bold.
FIG. 3. Correlation between the percentage of 47 large cells
with RV-SIg and fecal (a) and plasma (b) IgM titers (log 2 of the
reciprocal last dilution the plasma or stool that was positive by ELISA)
in children with RV-induced diarrhea. Measurements of RV-SIg cells
used for these correlations were from samples of the acute and
convalescent phase of the disease (Table 2). Statistical analysis was
done with Spearman’s test.
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of RV-ASC, in children with RV diarrhea occurs between
3 and 6 DAOD. The total ASC of children with RV diarrhea
(Table 3) are, at each time point, roughly 10 times the
numbers of RV-ASC (data not shown). This finding sup-
ports our conclusion of the kinetics of RV-specific ASC. In
agreement with the results of previous investigators, in
the majority of children, the predominant isotype of the
RV-ASC was IgM (Kaila et al., 1992). The magnitude and
isotype of the responding RV-ASC did not show any
apparent relation with the age of the children or the fact
that the response was primary or secondary (Table 3).
To compare the characteristics of RV-ASC in children
with RV-induced diarrhea to those of children with diar-
rhea of another origin, we performed ELISPOTS in chil-
dren with non-RV-induced diarrhea (Table 4). In 5 of 10
children in the acute phase of non-RV-induced diarrhea
we could detect low numbers of RV-ASC. When the
assay was repeated 2 weeks later in four of the children,
the ASC had completely disappeared (Table 4, subjects
C 33, C 34, C 37, C 38). The presence of RV-ASC during
the acute phase in these children had no evident corre-
lation with the child’s age or the fact that the child had
previously been infected or not by RV, as evidenced by
the presence of RV-specific IgA in either plasma or feces
(Table 4). The IgM RV-ASC response of children with
RV-induced diarrhea (Table 3) was statistically different
from the IgM RV-ASC response of children with non-RV-
induced diarrhea (P  0.018 Mann–Whitney test). The
IgG and IgA RV-ASC response of children with RV-in-
duced diarrhea was not statistically different from the
response of IgG and IgA RV-ASC of children with non-
RV-induced diarrhea (P  0.07 Mann–Whitney tests).
Probably because children with non-RV diarrhea are
also responding to an intestinal pathogen, the total IgM,
IgG, and IgA ASC response of children with RV-induced
diarrhea was not statistically different from the IgM, IgG,
and IgA response in children with non-RV-induced diar-
rhea (data not shown).
Quantification of RV-ASC in recently and not recently
RV-infected adults
We performed ELISPOTS in adults with recent RV in-
fection at different DAOD and compared these results
with the RV-ASC detected in children with RV-induced
diarrhea. In adults the numbers of RV-ASC varied as a
function of DAOD (Fig. 4): Five adults tested between
12 h and 4 DAOD had low (less than 60 ASC per 106
PBMC) or undetectable ASC (one subject). Five adults
tested between 5 and 9 DAOD had over 100 RV-ASC per
106 PBMC. Five adults tested between 13 and 32 DAOD
evidenced low (less than 60 ASC per 106 PBMC) or
undetectable ASC (two subjects). Thus, the peak of cir-
culating RV-ASC in adults with RV-induced diarrhea
seems to be between 5 and 9 DAOD. In contrast to the
responses observed in children, the predominant iso-
types secreted by the RV-ASC in adults were IgA or IgG,
and the numbers of ASC were roughly 10 to 100 times the
numbers of ASC present in children (Fig. 4). In two of
three samples taken from asymptomatic guardians/par-
ents of children with RV-induced diarrhea (samples taken
in the convalescent phase of the child’s diarrhea) we
could also detect RV-ASC of IgG (mean 32.5 ASC per 106
PBMC) and IgA (mean 25.5 ASC per 106 PBMC) but not
IgM isotype.
To determine if nonrecently infected adults or adults
with diarrhea of non-RV origin had circulating RV-ASC,
we performed ELISPOTs with PBMC of 15 healthy adults
and 6 adults with non-RV diarrhea. We could detect
RV-ASC in only 3 of these 21 subjects (14%): one healthy
adult had 10 IgG ASC per 106 PBMC; 1 adult with non-
RV-induced diarrhea had 10 IgA RV-ASC, and another
symptomatic adult had IgM (mean 14 ASC per 106 PBMC)
and IgA (mean 12.5 ASC per 106 PBMC) RV-ASC in three
consecutive samples (data not shown). The response of
IgM, IgG, and IgA RV-ASC of adults with RV-induced
diarrhea (Fig. 4) was statistically different from the re-
sponse of IgM, IgG, and IgA RV-ASC of healthy adults
and adults with non-RV-induced diarrhea (P  0.01
Mann–Whitney test).
Phenotype of RV-ASC
To determine if RV-ASC express the intestinal homing
receptor, we purified 47 and 47 subsets with
microbeads from selected subjects prior to performing
the ELISPOT assays. As can be seen in Table 5, in both
children and adults, the majority of IgA RV-ASC express
the intestinal homing receptor. In the three children stud-
TABLE 4
RV-ASC of IgM, IgG and IgA Isotype in Children
with Non-RV-Induced Diarrhea
Subjects
Age
(months) DAOD RV IgAa
Number of ASC per
106 PBMC
IgM IgG IgA
C 30 7 1.5 No 0 0 0
C 31 5 2 No 2 4 0
C 32 12 2 No 0 2 0
C 33 19 2.5 Yes 2 2 0
C 34 15 2.5 No 2 0 0
C 35 8 3.5 No 0 0 7
C 36 10 3.5 No 0 0 0
C 37 11 4 No 0 0 0
C 38 9 4 Yes 0 0 0
C 39 20 4 Yes 0 4 4
C 38 9 14 Yes 0 0 0
C 34 15 14.5 No 0 0 0
C 33 19 15.5 Yes 0 0 0
C 37 11 30 No 0 0 0
a Presence of RV IgA in plasma or stool samples of the children
indicating previous infection with RV.
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ied, from 59 to 100% of the IgA RV-ASC expressed 47.
From 68 to 100% of the IgA RV-ASC expressed 47 in
the four adults studied. In three of the four adults, IgG
ASC also predominantly express the intestinal homing
receptor. In one child (C 21) we could determine that IgM
ASC also preferentially express 47. In the two other
children in which we studied spots formed by IgM ASC,
the presence of background (spots in wells coated with
PBS) did not permit conclusions. In one of two adults in
whom we tried to characterize IgM RV-ASC, a similar
level of background ASC was found. Since background
levels that exceeded 50% of IgM RV-ASC are more fre-
quent in experiments performed after microbead purifi-
cation of cells (found in three of five experiments, Table
5) than in ELISPOTS where cells were not purified with
microbeads (lower than 3% of the experiments), it is
possible that the cell purification process we have used
increases the levels of polyreactive IgM ASC. Thus, in
children, IgA RV-ASC predominantly express 47, but
future studies are needed to determine if IgM RV-ASC
also express the intestinal homing receptor in children.
Correlation between circulating B cells with RV-SIg
and the presence of RV-ASC
We were able to perform eight experiments with PBMC
of children in which we simultaneously performed the
ELISPOT and flow cytometry assay. The results of total
RV-SIg large B cells (the sum of 47 and 47 cells
from Table 2) and total RV-ASC (the sum of RV specific
IgM, IgG, and IgA from Table 3) from these experiments
are shown for comparison in Table 6. In four of these
experiments, done with cells from children in the acute
phase of the disease, there is a correlation (P  0.01;
r  1 Spearman’s test) between the number of RV-ASC
and cells with RV-SIg. In contrast, in the four experiments
with cells from convalescent children there is no statis-
tically significant correlation (P  0.26; r  0.73 Spear-
man’s test). This result suggests that while in the acute
phase of the disease the cells detected by ELISPOT and
flow cytometry are highly overlapping; in the convales-
cent phase they are not.
DISCUSSION
We have determined that, after an acute rotaviral in-
fection, B cells that express RV-SIg or RV-ASC both pref-
erentially express 47, the intestinal homing receptor.
Thus, circulating RV-specific B cells have the phenotype
predicted for cells stimulated in PP (Butcher et al., 1999).
These results are in agreement with our previous find-
ings in the mouse model (Franco and Greenberg, 1999;
experiments with the PBMC from another subject, two experiments
with the PBMC from three subjects, and one experiment from four
independent subjects).
FIG. 4. RV-ASC of IgM (top), IgG (middle), and IgM (bottom) isotype
in adults with RV-induced diarrhea according to DAOD. Shown are the
results with PBMC of nine subjects obtained at different DAOD and
tested in the ELISPOT assay. In all, 18 individual ELISPOT experiments
are shown (five experiments with the PMBC from one subject, three
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Kuklin et al., 2001; Williams et al., 1998) that indicated
that 47 is critical for the development of a protective
humoral immune response against RV. They are also in
agreement with several other studies of human ASC
directed against various intestinal pathogens which de-
termined that these ASC were enriched in 47 cells
(Herremans et al., 1999; Kantele et al., 1997; Quiding-
Ja¨rbrink et al., 1997).
We found that children with RV-induced diarrhea have
a lower ratio of 47 to 47 cells among the large
RV-SIg cells than adults (Fig. 2b). The relative increase in
RV-SIg 47 cells in children with RV-induced diarrhea
could be explained if these cells are derived from sys-
temically primed B cells. This hypothesis might imply that
in children significant quantities of rotaviral antigen
reach systemic lymphoid organs such as the spleen
especially after primary infection. This event could occur
by the migration to the spleen of antigen-presenting cells
with associated viral antigen captured in PP or by the
direct access of infectious virus to blood and then to
spleen. In support of this latter hypothesis several stud-
ies have proposed the possibility for extraintestinal dis-
semination of RV in children (Abe et al., 2001). The
development of some degree of RV immunity in all adults
would tend to restrict or eliminate systemic spread of
antigen during secondary infection. Another possible ex-
planation for the relative increase of RV-SIg 47 cells
in children could be that the capacity of B cells to up-
regulate 47 is diminished in children relative to adults.
This alternative hypothesis is supported by studies in
mice that show 47 is developmentally regulated (Me-
bius et al., 1996). Nonetheless, in humans this is not
likely because neonate’s B cells express similar or more
47 on their surface than adults B cells (Erle et al.,
1994).
The relationship between RV-ASC and B cells with
RV-SIg is not completely clear from our study. Since
approximately 50% of human ASC express surface Ig
(Lakew et al., 1997), it is very probable that the RV-ASC
and RV-SIg B cells we have detected are partially over-
lapping populations but that not all RV-ASC are detected
by the flow cytometry assay. The correlation we detected
between total RV-SIg B cells and total RV-ASC (Table 6) in
the children during the acute phase of the disease sup-
ports the hypothesis that during this phase these two
groups of B cells are highly overlapping. Flow cytometry
assay in the mouse model is able to detect a subpopu-
lation of B cells that are not secreting antibodies (Young-
man et al., 2002). This is also likely to be the case in the
present human studies as evidenced by the two children
(C03 and C09, Table 6) in the convalescent phase that
have detectable high levels of RV-SIg B cells with very
low or no detectable RV-ASC (Table 6). The cells de-
tected in the convalescent phase by the flow cytometry,
but not detected by ELISPOT, could include early mem-
TABLE 5
Phenotype of RV-ASC of IgM, IgG, and IgA Isotype in Children and Adults with RV Diarrhea
Subjects Age Primary infectiona DAOD
Number of 47 RV-ASC per 106 PBMC (%)b
IgM IgG IgA
C 21 5 months Yes 3 6 (85) ND ND
C 08 10 months No 4 0c ND 27 (100)
C 23 30 months Yes 4.5 ND 4 (100) 40 (59)
C 40 12 months Yes 6 0c ND 180 (90)
A 08 28 years No 3 0c 0 11 (100)
A 09 22 years No 5 ND 49 (71) 127 (68)
A 01 28 years No 5 ND 540 (46) 400 (87)
A 10 30 years No 6 0 298 (96) 372 (100)
A 11 28 years No 13 ND 12 (85) 132 (91)
a Determined by the absence of RV-specific IgA in plasma or stool samples from the acute phase sample of the child and plasma samples from
the adults.
b The percentage of 47 RV-ASC was calculated by the formula: number of spots from wells with 47 cells  100/numbers of spots in wells
with 47 cells  spots in wells with 47 cells. ND, not done.
c These values are reported as 0 because of the presence of more than 50% ASC in wells coated with PBS and incubated with 47 cells.
TABLE 6
Correlation between Total RV-SIg Large B Cells and Total RV-ASC
Subjects DAOD Total RV-SIga Total RV-ASCb
C 01 1.5 0.93 19
C 02 2 5.4 982.5
C 03 4 0.26 13.5
C 04 4 3.09 48
C 09 14 8.16 2
C 10 15 2.21 35
C 01 23 0.21 0
C 03 23 0.9 0
a The sum of 47 and 47 large B cells from Table 2.
b The sum of IgM, IgG, and IgA RV-ASC from Table 3.
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ory B cells (Youngman et al., 2002). In support of this
interpretation, preliminary results from our laboratory
show that RV-SIg B cells in children with RV-induced
diarrhea express high and low levels of CD38 (a marker
of ASC) in the acute and convalescent phase of the
infection, respectively.
Our previous studies in the mouse model have shown
that small (but not large) RV-SIg B cells are present up to
9 months after infection in PP, and that this population
does not include any RV-ASC, indicating that they are
memory B cells (Youngman et al., 2002). Although we
found no statistically significant differences between the
small B cells with RV-SIg from infected and noninfected
individuals, there was a trend for higher levels of 47
cells in the symptomatically RV-infected adult group (Fig.
2a). It is possible that this population includes RV-spe-
cific memory B cells. Very few studies have used a flow
cytometry based assay such as ours to study the phe-
notype of human memory B cells that express surface Ig
for a specific antigen (Leyendeckers et al., 1999). In the
mouse model this type of analysis has been instrumental
in defining the phenotypic characteristics of effector and
memory B cells (McHeyzer-Williams et al., 1993). Our
experimental system may thus prove useful to study
basic phenotypic characteristics of circulating human
antigen-specific B cells.
The presence of low levels of RV-ASC in children with
non-RV diarrhea and in a few nonrecently RV-infected
adults (with or without diarrhea) was somewhat unex-
pected. The fact that these low-frequency cells are
present equally among children with or without evidence
of a previous RV infection as determined by the presence
of stool or plasma IgA suggests that these cells could be
polyreactive “background” B cells. This hypothesis would
be in accord with other studies of human ASC specific
for intestinal antigens that have shown that the presence
of these ASC in peripheral blood is very short lived (1 or
2 weeks) after administration of the antigen (Kantele,
1990). Nonetheless, as suggested by investigators that
have found the presence of circulating RV-ASC in healthy
older children, RV could be unique as an antigen in that
there is prolonged circulation in blood of low levels of
RV-ASC (Brown et al., 2000). A similar issue is raised by
the presence of B cells (both large and small) with RV-SIg
among PBMC of the subset of children with non-RV-
induced diarrhea and who did not have evidence of
previous RV infection as indicated by the presence of
stool or plasma IgA. The levels of these cells are similar
to their counterparts in healthy adults (Fig. 2). Thus, it is
uncertain at present if the low levels of B cells with
RV-SIg found in healthy adults represent true RV-specific
memory B cells or the background level of our assay. The
creation of fluorescent VLP with antigens not commonly
encountered in our populations should help clarify this
issue as would the molecular cloning and characteriza-
tion of the immunoglobulin genes from such B cells.
Although we found a correlation between large 47
RV-SIg cells and fecal IgM, these cells did not correlate
with stool IgA (Fig. 3). In addition the correlation with
stool IgM was not very strong and many of the children
studied for this correlation did not develop RV-specific
stool IgM antibodies (Fig. 3). The lack of correlation
observed between large 47 RV-SIg cells and stool
IgA, and the relatively low correlation with stool IgM,
could be explained by the low number of volunteers
studied, lack of measurement of the stool antibodies at
their peak (to early after infection), or inherent technical
problems with the measurement of fecal antibodies
(Franco and Greenberg, 2001). Thus although our results
suggest that, as predicted by the intestinal homing
model, the presence of large 47 R-SIg cells can
predict the levels of intestinal antibodies, future work is
necessary to establish this. Our finding that large 47
RV-SIg cells but not large 47 RV-SIg cells correlate
with the presence of RV-specific plasma IgM (Fig. 3)
suggests that most of this antibody is produced by the
putatively mucosal primed cells and not by putatively
systemically primed cells. This finding is in agreement
with reports that serum IgA virus-specific antibodies ob-
served up to 40 days after infection (but not in the late
convalescent period) are dimeric and thus probably of
mucosal origin (Brown et al., 1985; Negro Ponzi et al.,
1985).
A major impediment during the development of RV
vaccines is the lack of good markers of protection
(Franco and Greenberg, 2001). Fecal RV-specific anti-
body levels have been measured in a few vaccine stud-
ies but have not correlated well with protection, perhaps
because they have not been measured at the appropri-
ate time or because of inherent technical problems with
the measurement of fecal IgA (Franco and Greenberg,
2001). In humans, blood circulating ASC have been re-
cently shown to correlate with the presence of RV-spe-
cific IgA ASC in the small intestine of healthy children
(Brown et al., 2000) and antigen-specific ASC have been
proposed as a marker of protection induced by oral
salmonella vaccines (Kantele, 1990). In contrast to ASC
that seem to be only transiently present in blood (Table 3
and Kaila et al., 1992), the large 47 RV-SIg cells
seem to be detected persistently in the acute and con-
valescent phase of the disease in children, making them
more amenable to study. This could be because, as
suggested above, some of these cells could be early
memory B cells. Furthermore, the correlation (Fig. 3)
between large 47 cells with convalescent plasma
IgM, that is the most sensitive marker for immunogenic-
ity of natural RV infection (Grimwood et al., 1988), indi-
cates that the flow cytometry assay could be very useful
for measuring the immune response to natural RV infec-
tion. For all these reasons, the measurement of the large
47 RV-SIg cells could be useful for studying the
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immunogenicity and in predicting protective efficacy of
RV vaccines.
MATERIALS AND METHODS
Subjects and sample collection
The study population consisted of children (n  40,
age range 3.5 to 39 months) that were seen in the
pediatric emergency room of the San Ignacio Hospital,
Bogota´, Colombia for acute diarrhea. Samples were also
obtained from the adult guardians or parents (n  31,
age range 18 to 66 years) of these children. Stool and
blood samples or saliva and blood samples were ob-
tained from children and adult guardian, respectively,
during the acute phase of the RV disease of the child
(from 1 to 7 DAOD). When possible, specimens were
obtained from the same subjects during the convales-
cent phase (8 to 30 DAOD). Medical students (n  3)
that presented with diarrhea during their rotation on the
pediatric ward of the Hospital San Ignacio or healthy
laboratory workers (n  3) and healthy adults (n  6)
without known RV exposure were also studied. Informed
consent for participation in this study was obtained from
all adult subjects and from the guardians/parents of the
children. This project was approved by the ethics com-
mittee of the San Ignacio Hospital.
Blood was collected in heparin-containing tubes and
centrifuged at 250 g for 5 min and the plasma was
collected and stored at 20°C. Stool samples were
aliquoted and stored at 70°C and saliva was centri-
fuged at 500 g for 15 min aliquoted and stored at 20°C.
PBMC were isolated by density gradient centrifugation
using Ficoll–Hypaque (Histolab Ltda., Bogota´, Colombia).
Cells were washed twice with phosphate-buffered saline
(PBS, Histolab Ltda.) plus 2% fetal calf serum (FCS,
Gibco-BRL, Gaithersburg, MD) and resuspended in RPMI
containing 20 mM HEPES, 100 U penicillin/ml, 100 mg/ml
streptomycin (Histolab Ltda.), plus 5% FCS and 5  105
M final -mercaptoethanol (Sigma, St. Louis, MO), re-
ferred to as complete medium. Samples were either
tested freshly for the ELISPOT or flow cytometry assay or
kept frozen at 70°C in FCS containing 10% dimethyl
sulfoxide (Sigma) for use in the flow cytometry assay.
ELISA for measuring RV Ag in feces
The presence of RV antigen in feces was determined
using an enzyme-linked immunosorbent assay (ELISA),
as previously described (Franco and Greenberg, 1997)
with minor modifications (Gilchrist et al., 1987). Immulon
2 ELISA plates (DYNEX Technologies, Chantilly, VA) were
coated with 70 l/well of rabbit anti-RV hyperimmune
serum or preimmune serum diluted in PBS (Histolab
Ltda.) and incubated overnight at 4°C. Wells were then
blocked with 150 l of 5% nonfat powdered milk plus
0.1% Tween-20 in PBS (5% blotto) for 30 min at 37°C.
Blocking solution was removed and 70 l of 10% stool
samples diluted in 5% blotto were added to both the
immune and the preimmune serum-coated wells. After
45 min of incubation at 37°C, the wells were washed five
times with PBS 0.1% Tween-20 (PBS–Tween) and 70 l of
guinea pig anti-rhesus RV hyperimmune serum diluted in
2.5% blotto plus 1.5% normal goat serum was added to
each well for 45 min at 37°C. After five washes with
PBS–Tween, 70 l of biotinylated goat anti-guinea pig
serum (Vector, Burlingame, CA) diluted in 2.5% blotto,
1.5% normal goat serum was added to each well. After 30
min of incubation at 37°C, the wells were washed five
times and 70 l peroxidase Avidin-Biotin Complex Kit
(ABC Kit, Vector) was added to each well and incubated
for 30 min at 37°C. After five washes with PBS–Tween,
plates were developed using 70 l tetramethyl benzidine
substrate (TMB, Sigma). The reaction was stopped by the
addition of 17.5 l 2 M sulfuric acid. Absorbance was
read at a wave length of 450 nm on an ELISA plate
reader (MR 2600 Dynatech, McLean, VA). Serial dilutions
of a supernatant from RF virus-infected MA104 cells
(positive control) and a known RV–human fecal speci-
men (negative control) were included in each plate. Sam-
ples, tested in duplicate, were considered positive if the
optical density in the experimental well was 0.1 optical
density units and twofold greater than the optical density
in the corresponding control wells coated with preim-
mune serum and incubated with the same RV–stool
sample suspension. Only plates in which the lowest
dilution of the RF supernatant known to be positive was
positive and the negative stool sample was negative
were accepted for analysis.
ELISA for measuring RV-specific antibodies in
plasma, saliva, and feces
For detection of RV-specific IgA and IgG, 96-well Im-
mulon 2 microtiter plates (Dynex Technologies) were
coated with 70 l of 1/10 dilution (in PBS pH 7.4) of
supernatant from RF virus-infected MA104 cells [107
plaque forming units (PFU)/ml] or the supernatant of
mock-infected MA104 cells (negative control) in PBS pH
7.4 and incubated overnight at 4°C. After discarding
these solutions, 150 l 5% blotto was added to the plates
and incubated at 37°C for 1 h. Then the blotto was
discarded and 70 l of the dilutions of plasma, stool
samples, or saliva in 2.5% blotto were deposited in each
well. After 2 h incubation at 37°C, the plates were
washed five times with PBS–Tween, and 70 l of biotin-
labeled goat anti-human IgA or IgG (Kirkegaard and
Perry Labs, Gaithersburg, MD) diluted in 2.5% blotto was
added to the plates and incubated for 1 h at 37°C. After
five washes with PBS–Tween, 70 l streptavidin–peroxi-
dase (Kirkegaard and Perry Labs) diluted in PBS was
added and the plates were incubated for 1 h at 37°C.
After five washes with PBS–Tween, the plates were de-
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veloped using TMB substrate as described above for the
antigen ELISA.
For detection of RV-specific IgM we used an assay
previously described by Coulson et al. (1989). ELISA
plates were coated overnight with 70 l of goat F(ab)2
(0.7 g) anti-human IgM (Biosource International, Cam-
arillo, CA) in PBS pH 7.4. The plates were then blocked
and incubated with dilutions of plasma or stool samples
as described above for the IgA and IgG ELISA. After two
washes with PBS–Tween, 70 l of a 1/10 dilution of
supernatant from RF virus (107 PFU/ml) infected MA104
cells or mock-infected cell supernatant was added to
individual wells in PBS pH 7.4 and incubated for 1 h at
37°C. Plates were then washed twice with PBS–Tween
and guinea pig anti-rhesus RV hyperimmune serum (di-
luted in 2.5% blotto–1.5% goat serum) was added to each
well and incubated for 1 h at 37°C. After three washes
with PBS–Tween, 70 l of biotin-labeled goat anti-guinea
pig (Vector) in 2.5% blotto–1.5% normal goat serum was
added and incubated for 1 h at 37°C. After three washes
with PBS–Tween, 70 l streptavidin–peroxidase was
added to each well. The assay was developed as de-
scribed above for the RV antigen ELISA. A plasma or
stool sample from a non-RV-infected child and serial
dilutions from a recently RV-infected adult were included
on each plate. The titer of a plasma was defined as the
reciprocal of the last dilution exceeding an optical den-
sity of 0.1 and that was twice the optical density of wells
treated with mock. To be accepted for analysis, the titer
of the positive control plasma in a plate could not differ
by more than one dilution from plate to plate.
Definitions
A child was considered infected by RV if (1) viral
antigen was detected by ELISA in either of its stool
samples (acute or convalescent); (2) stool virus-specific
IgM specimens had a titer greater than 1/2 in either
sample; (3) a plasma titer greater than 1/400 for RV-
specific IgM was found in either sample; (4) the child’s
stool IgA converted (fourfold increase in virus-specific
titers between the acute and convalescent sample); (5)
the child’s plasma demonstrated a conversion in IgA or
IgG (fourfold increase in virus-specific titers between the
acute and convalescent sample) (Coulson et al., 1989,
1992). A child was considered to have diarrhea of an-
other origin if he/she met none of the above criteria for
acute RV infection. Two children with diarrhea from
whom only an acute phase plasma sample was available
and who did not have RV antigen or RV-specific antibod-
ies in either the acute or the convalescent stool or acute
plasma samples were also considered as non-RV-in-
fected. All healthy adults and healthy parents/guardians
of non-RV-infected children were considered to be non-
recently RV infected. Adults with acute diarrhea or
asymptomatic parent/guardians of children with acute
RV-induced diarrhea were classified as recently infected
or not recently infected with RV using the same criteria
as for children with diarrhea, but replacing measure-
ments of virus-specific stool IgM and IgA with the mea-
surement of saliva-specific IgA. Recently infected adults
that did not present with diarrhea were classified as
“asymptomatic” recently infected individuals.
Production of fluorescent VLP
Production of fluorescent RV VLPs (GFP-VLPs) in the
baculovirus expression system has been described
(Charpilienne et al., 2001). Briefly Sf9 cells were coin-
fected with two recombinant baculoviruses at a multiplic-
ity of infection greater than 5 PFU/cell. One baculovirus
expressed of RF VP6 and the other a fusion protein
consisting of green fluorescence protein (GFP) fused to
the N-terminus of RF VP2 deleted of the first 92 residues.
Infected cultures were collected 5–7 days postinfection,
treated with Freon 113, purified by density gradient cen-
trifugation in CsCl in 20 mM PIPES 10 M CaCl2 buffer,
and finally resuspended in TNC buffer [10 mM Tris (pH
7.4), 140 mM NaCl, 10 mM CaCl2]. The concentration of
protein in the purified VLP suspension was estimated by
the method of Bradford using BSA as standard. Cryoelec-
tron micrographs of GFP-VLPs and VLPs formed by na-
tive VP2 and VP6 are indistinguishable by the naked eye
and their 3D reconstructions reveal an identical surface
(Charpilienne et al., 2001).
Flow cytometry assay
PBMC (fresh or frozen and thawed) were washed once
with staining buffer containing PBS–0.5% bovine serum
albumin (BSA, Sigma)–0.02% sodium azide (Sigma). Pel-
lets containing 1–3  106 cells were resuspended and
incubated with 0.8 g of GFP-VLPs. After 45 min of
incubation in the dark at 4°C, cells were washed and
then labeled with anti-human monoclonal antibodies
(Mab) against CD19 labeled with allophycocyanin
(Pharmingen, La Jolla, CA), biotinylated goat anti-human
IgD (Southern Biotechnology Inc., Birmingham, AL), phy-
coerythrin-labeled anti-47 (obtained from Charles
Mackay Leukosite Inc., Cambridge, MA and commer-
cially labeled to phycoerythrin by Chromoprobe, Moun-
tain View, CA) for 45 min in the dark at 4°C. Then, cells
were washed and labeled with peridinine clorophyll pro-
tein-conjugated streptavidin (Becton–Dickinson, San
Jose, CA). After incubation for 45 min in the dark at 4°C,
cells were washed in staining buffer and resuspended in
300 l 1% paraformaldehyde (Carlo ERBA Reagenti, Ro-
dano, MI) and analyzed on a flow cytometer (FACSCALI-
BUR, Becton–Dickinson) equipped with a second 635-nm
red diode laser. At least 105 CD19 cells were acquired
per sample. As a guide for setting markers to delineate
positive and negative cell populations and control for the
specificity of the staining, control cells were labeled with
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phycoerythrin-Rat IgG isotype matched control Mab, with
peridinine clorophyll protein-conjugated streptavidin and
anti-CD19 Mab allophycocyanin. Analysis of data files
was performed using CellQuest Software (Becton–Dick-
inson).
B cell ELISPOT
ASC were evaluated by an ELISPOT assay (Franco
and Greenberg, 1997). Individual wells of a 96-well plate
(Immobilon P membrane, Millipore, Bedford, MA) were
coated with 0.28 g of cesium-purified RF (bovine RV)
diluted in 70 l of sterile PBS, or 0.7 g each of Mab
anti-kappa and Mab anti-lambda (Kirkegaard and Perry
Labs), diluted in 70 l of sterile PBS (for detection of total
ASC) or 70 l of sterile PBS (for detection of nonspecific
ASC) and incubated overnight at 4°C. After discarding
these supernatants plates were incubated with 200 l
complete medium for 30 min at 37°C–5% CO2. PBMC
were obtained from total blood using a Ficoll density
gradient, washed twice with PBS–2% FCS, and then
resuspended in complete medium. Serial dilutions (start-
ing with 5  105 cells per well) of the cells were depos-
ited in each well in a final volume of 100 l. The cells
were incubated for 4 h at 37°C–5% CO2 and then washed
with PBS once and four more times with PBS–Tween.
HRP-conjugated goat anti-human IgG, anti-IgA, or anti-
IgM (Sigma) suspended in PBS–1% BSA–0.05%
Tween-20 were then added and incubated for 4 h at 37°C
and then washed five times with PBS–Tween. The assay
was developed with 3-amino-9-ethylcarbazole solution
(Vector) incubated for 20 min at room temperature. The
reaction was stopped with water and then the spots
were counted using a 10 magnifying glass. Spots were
identified as having a distinct and intense center with
decreasing radial contrast. Spots that were irregular or
without the decreasing radial contrast were not counted.
Background spots were detected in less than one-third
of the experiments performed. The background spots
were equally distributed among RV-infected and nonin-
fected adults and children. Background ASC of all iso-
types were detected and were subtracted from RV-ASC if
they did not exceed 50% of the value of RV-ASC. When
background ASC represented over 50% of RV-ASC (a
situation that occurred in less than 10% of the cases
when background ASC were present), the RV-ASC were
reported as O ASC per million cells. In 57 and 33% of the
other cases when background ASC were present, back-
ground ASC represented less than 20% and between 20
and 50% of the number of RV-specific ASC.
Purification of B cell subsets with microbeads
A suspension of PBMC in PBS–0.5% BSA was incu-
bated with 3 g purified mouse anti-human anti-47
Act-1 (Obtained from Charles Mackay Leukosite Inc.) for
30 min at 4°C; then the cells were washed with the same
buffer and centrifuged at 250 g for 10 min. Microbeads
attached to a human anti-mouse IgG Mab by a DNA
linker (Cellection Pan mouse IgG Dynabeads, Dynal,
Oslo, Norway) were then added to the cell suspension
and incubated for 1 h at 4°C. The cells were separated
with a magnet according to the manufacturer’s instruc-
tions to obtain positively and negatively selected cells.
The cells were then counted, resuspended in complete
medium, and deposited in wells of ELISPOT plates
coated or not with purified RV as described above. The
negatively selected cells were stained with phyco-
erythrin-labeled anti-7 antibody FIB504 (Pharmingen)
and analyzed by flow cytometry to determine the purity of
the selected cells. As reported by others (Kantele et al.,
1997; Quiding-Ja¨rbrink et al., 1997), these cells were over
91% pure.
Statistical analysis
Statistical analysis was performed with SPSS software
version 8.0 (SPSS Inc., Chicago, IL) using nonparametric
tests. Differences between groups were evaluated with
the Kruskal–Wallis test followed by Mann–Whitney tests.
Differences between paired results with in a study group
were compared with the Wilcoxon test. Correlation be-
tween groups were analyzed with Spearman’s test. Sig-
nificance was established if P  0.05. Data are shown
as mean, SEM unless otherwise noted.
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